|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.56 CNY | +2.77% |
|
+5.22% | -4.97% |
| 06-09 | China Approves Aodong Subsidiary's Levocarnitine Injection | MT |
| 05-21 | Jilin Aodong Pharmaceutical Gets China Approval for Supplemental Registration of Heart Drug | MT |
| Market Cap | 21.76B 3.22B 2.82B 2.6B 2.39B 4.53B 310B 4.6B 31.13B 12.19B 152B 12.08B 11.81B 523B | P/E 2024 |
13.1x | P/E 2025 | 9.57x |
|---|---|---|---|---|---|
| Enterprise Value | 21.04B 3.11B 2.72B 2.52B 2.31B 4.37B 300B 4.45B 30.1B 11.78B 147B 11.67B 11.42B 506B | EV / Sales 2024 |
7.76x | EV / Sales 2025 | 9.49x |
| Free-Float |
67.59% | Yield 2024 |
2.9% | Yield 2025 | 2.56% |
| 1 day | +2.77% | ||
| 1 week | +5.22% | ||
| Current month | +4.68% | ||
| 1 month | +8.22% | ||
| 3 months | +1.92% | ||
| 6 months | -8.16% | ||
| Current year | -4.97% |
| 1 week | 17.27 |  | 18.79 |
| 1 month | 17.08 | | 18.88 |
| Current year | 16.36 | | 20.93 |
| 1 year | 16.36 | | 22.08 |
| 3 years | 12.49 | | 22.08 |
| 5 years | 12.49 | | 22.08 |
| 10 years | 12.49 | | 29.43 |
| Manager | Title | Age | Since |
|---|---|---|---|
Shu Qin Guo
CEO | Chief Executive Officer | 63 | 2017-07-16 |
Kai Yang
DFI | Director of Finance/CFO | 49 | 2004-04-30 |
Shu Yuan Zhang
DFI | Director of Finance/CFO | 54 | 2007-06-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Xiu Lin Li
CHM | Chairman | 73 | 2005-05-17 |
Shu Qin Guo
BRD | Director/Board Member | 63 | 2000-01-31 |
Yong Feng Chen
CHM | Chairman | 59 | 2017-07-16 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/25/25 | Buy | 100 | 0.0000% | |||
| 7/29/24 | Buy | Chief Executive Officer | 320,000 | 0.0276% | ||
| 7/29/24 | Buy | Chairman | 350,000 | 0.0302% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.77% | +5.22% | +0.81% | +12.83% | 3.12B | |
| -2.73% | -3.51% | +48.62% | +152.87% | 1,051B | |
| -1.67% | -3.18% | +52.00% | +56.75% | 609B | |
| -0.44% | +2.14% | +33.88% | +84.04% | 450B | |
| -0.75% | -1.46% | +28.32% | +22.33% | 330B | |
| -1.52% | -0.95% | +33.38% | +38.39% | 284B | |
| -1.70% | -3.54% | +20.26% | +17.88% | 263B | |
| -0.58% | +1.78% | -20.89% | -38.37% | 223B | |
| -0.58% | +0.21% | +23.55% | +56.94% | 198B | |
| -0.80% | +2.60% | +23.09% | +68.71% | 167B | |
| Average | -0.35% | +0.86% | +24.30% | +47.24% | 357.82B | |
| Weighted average by Cap. | -0.47% | +0.03% | +35.22% | +75.52% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.61B 386M 338M 312M 287M 543M 37.21B 552M 3.74B 1.46B 18.2B 1.45B 1.42B 62.78B | 2.34B 346M 302M 279M 257M 486M 33.28B 493M 3.34B 1.31B 16.28B 1.3B 1.27B 56.16B |
| Net income | 1.55B 230M 201M 186M 171M 323M 22.11B 328M 2.22B 869M 10.82B 861M 842M 37.31B | 2.4B 354M 310M 287M 263M 498M 34.14B 506M 3.43B 1.34B 16.7B 1.33B 1.3B 57.6B |
| Net Debt | -386M -57.12M -49.96M -46.19M -42.45M -80.27M -5.5B -81.56M -552M -216M -2.69B -214M -210M -9.28B | -724M -107M -93.71M -86.64M -79.63M -151M -10.32B -153M -1.04B -406M -5.05B -402M -393M -17.41B |
Employees
5,461
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-20 | CN¥18.56 | +2.77% | 24,793,920 |
| 26-07-17 | CN¥18.06 | -3.01% | 21,590,952 |
| 26-07-16 | CN¥18.62 | -0.21% | 20,506,958 |
| 26-07-15 | CN¥18.66 | +4.30% | 27,751,556 |
| 26-07-14 | CN¥17.89 | +2.23% | 15,633,702 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 000623 Stock
Select your edition
All financial news and data tailored to specific country editions
